Pharmacogenomic application of the haptoglobin genotype in the treatment of HDL dysfunction

References

• SteinbergDParthasarathySCarewTEKhooJCWitztumJLBeyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicityN Engl J Med1989320149159242648148
   PubMed Web of Science ®Google Scholar
• NavabMAnantharamaiahGMReddySTVan LentenBJAnsellBJFogelmanAMMechanisms of Disease: proatherogenic HDL-an evolving fieldNature Clin Pract Endocrinol Metab20062950451116957764
   PubMedGoogle Scholar
• StockerRKeaneyJFRole of oxidative modifications in atherosclerosisPhysiol Rev20048441381147815383655
   PubMed Web of Science ®Google Scholar
• StockerRKeaneyJFNew insights on oxidative stress in the artery wallJ Thromb Haemost2005381825183416102049
   PubMed Web of Science ®Google Scholar
• RaderDJMolecular regulation of HDL metabolism and function: implications for novel therapiesJ Clin Invest2006116123090310017143322
   PubMed Web of Science ®Google Scholar
• KontushAChapmanMJFunctionally defective high density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosisPharmacol Rev200658334237416968945
   PubMed Web of Science ®Google Scholar
• FerrettiGBacchettiTNegre-SalvayreASalvayreRDoussetNCuratolaGStructural modifications of HDL and functional consequencesAtherosclerosis200618411716157342
   PubMed Web of Science ®Google Scholar
• NorataGDPirilloACatapanoALModified HDL: Biological and physiopathological consequencesNutr Metab Cardiovasc Dis200616537138616829346
   PubMed Web of Science ®Google Scholar
• WatanabeJChouKJLiaoJCDifferential association of hemoglobin with proinflammatory high density lipoproteins in atherogenic/hyperlipidemic miceJ Biol Chem200728232236982370717556366
   PubMed Web of Science ®Google Scholar
• GroopFHThomasMCRosenbard-BarlundMHDL composition predicts new onset cardiovascular disease in patients with Type I diabetesDiabetes Care200730102706270717620444
   PubMed Web of Science ®Google Scholar
• WuZWagnerMAZhengLThe refined structure of nascent HDL reveals a key functional domain for particle maturation and dysfunctionNat Struct Mol Biol200714986186817676061
   PubMed Web of Science ®Google Scholar
• ShaoBOdaMNVaiserTOramJFHeineckeJWPathways for oxidation of high-density lipoprotein in human cardiovascular diseaseCurr Opin Mol Ther20068319820516774039
   PubMedGoogle Scholar
• AnantharamaiahGMMishraVKGarberDWStructural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-1 mimetic peptidesJ Lipid Res20074891915192317570869
   PubMed Web of Science ®Google Scholar
• ShaoBOdaMNBergtCMyeloperoxidase impairs ABCA1-dependent cholesterol efflux through methionine oxidation and site-specific tyrosine chlorination of apolipoprotein A-1J Biol Chem2006281149001900416497665
   PubMed Web of Science ®Google Scholar
• BlumCBLevyRIEisenbergSHallMGoebelRHBermanMHigh density lipoprotein metabolism in manJ Clin Invest1977604795807197124
   PubMed Web of Science ®Google Scholar
• NobecourtEDaviesMJBrownBEThe impact of glycation on apolipoprotein A-1 structure and its ability to activate lecithin: cholesterol acyltransferaseDiabetologia200750364365317216278
   PubMed Web of Science ®Google Scholar
• AlexanderETBhatSThomasMJApolipoprotein A-1 helix 6 negatively charged residues attenuate lecithin-cholesterol acyltransferase (LCAT) reactivityBiochemistry200544145409541915807534
   PubMed Web of Science ®Google Scholar
• AslehRBlumSKalet-LitmanSCorrection of HDL dysfunction in individuals with diabetes and the haptoglobin 2–2 genotypeDiabetes200857102794280018599520
   PubMed Web of Science ®Google Scholar
• VivekananthanDPPennMSSappSKHsuATopolEJUse of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomized trialsLancet200336193742017202312814711
   PubMed Web of Science ®Google Scholar
• LonnEBoschJYusufSSheridanPHOPE and HOPE-TOO Trial InvestigatorsEffects of long-term vitamin E supplementation on cardiovascular events and cancerJAMA2005293111338134715769967
   PubMed Web of Science ®Google Scholar
• YusufSDagenaisGPogueJBoschJSleightPVitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study InvestigatorsN Engl J Med2000342315416010639540
   PubMed Web of Science ®Google Scholar
• Heart Protection Study Collaborative GroupMRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high risk individuals;a randomized placebo controlled trialLancet20023609326233312114037
   PubMed Web of Science ®Google Scholar
• WatersDDAldermanELHsiaJEffects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trialJAMA2002288192432244012435256
   PubMed Web of Science ®Google Scholar
• de GaetanoGCollaborative Group of the Primary Prevention ProjectLow-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention ProjectLancet20013579250899511197445
   PubMed Web of Science ®Google Scholar
• Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardicoLancet1999354917744745510465168
   PubMed Web of Science ®Google Scholar
• StephensNGParsonsASchofeldPMKellyFCheesemanKMitchinsonMJRandomized controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)Lancet199634790047817868622332
   PubMed Web of Science ®Google Scholar
• LeeIMCookNRGazianoJMGordonDRidkerPMMansonJEHennekensCHBuringJEVitamin E in the primary prevention of cardiovascular disease and cancer. The Women’s Health Study: a randomized controlled trialJAMA20052941566515998891
   PubMed Web of Science ®Google Scholar
• BrownBGCrowleyJIs there any hope for vitamin E?JAMA2005293111387139015769974
   PubMed Web of Science ®Google Scholar
• RedbergRFVitamin E and cardiovascular healthJAMA2005294110710915998898
   PubMed Web of Science ®Google Scholar
• MillerERBarriusoRPDalalDRiemersmaRAAppelLJGuallarEMeta-analysis: high-dosage vitamin E supplementation may increase all-cause mortalityAnn Intern Med20051421374615537682
   PubMed Web of Science ®Google Scholar
• BjelakovicGNikolovaDGluudLLSimonettiRGGluudCMortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysisJAMA2007297884285717327526
   PubMed Web of Science ®Google Scholar
• SteinbergDWitztumJLIs the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis?Circulation2002105172107211111980692
   PubMed Web of Science ®Google Scholar
• BoazMSmetanaSWeinsteinTSecondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomized placebo controlled trialLancet200035692371213121811072938
   PubMed Web of Science ®Google Scholar
• BlumSMilmanUShapiraCLevyAPPharmacogenomic application of the haptoglobin genotype in the prevention of diabetic cardiovascular diseasePharmacogenomics20089898999118681772
   PubMed Web of Science ®Google Scholar
• MilmanUBlumSShapiraCVitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both Type 2 Diabetes Mellitus and the Haptoglobin 2–2 genotype: a prospective, double-blinded clinical trialArterioscler Thromb Vasc Biol200828234134718032779
   PubMed Web of Science ®Google Scholar
• BowmanBHKuroskyAHaptoglobin: the evolutionary product of duplication, unequal crossing over, and point mutationAdv Hum Genet1982121892616751044
   PubMed Web of Science ®Google Scholar
• Melamed-FrankMLacheOEnavBIStructure-function analysis of the antioxidant properties of haptoglobinBlood200198133693369811739174
   PubMed Web of Science ®Google Scholar
• MillerYIAltamentovaSMShaklaiNOxidation of low-density lipoprotein by hemoglobin stems from a heme-initiated globin radical: anti-oxidant role of haptoglobinBiochemistry1997364012189121989315856
   PubMed Web of Science ®Google Scholar
• BammVVTsemakhovichVAShaklaiMShaklaiNHaptoglobin phenotypes differ in their ability to inhibit heme transfer from hemoglobin to LDLBiochemistry200443133899390615049697
   PubMed Web of Science ®Google Scholar
• LangloisMRDelangheJRBiological and clinical significance of haptoglobin polymorphism in humansClin Chem19964210158916008855140
   PubMed Web of Science ®Google Scholar
• GarbyLNoyesWDStudies on hemoglobin metabolism. The kinetic properties of the plasma hemoglobin pool in normal manJ Clin Invest1959381479148313826389
   PubMed Web of Science ®Google Scholar
• HershkoCThe fate of circulating hemoglobinBr J Haematol19752921992041103944
   PubMed Web of Science ®Google Scholar
• KristiansenMGraversenJHJacobsenCSonneOHoffmanHJLawSKMoestrupSKIdentification of the hemoglobin scavenger receptorNature2001409681719820111196644
   PubMed Web of Science ®Google Scholar
• GraversenJHMadsenMMoestrupSKCD163: a signal receptor scavenging haptoglobin hemoglobin complexes from plasmaInt J Biochem Cell Biol200234430931411854028
   PubMed Web of Science ®Google Scholar
• VaisarTPennathurSGreenPSShotgun proteomics implicates protease inhibition and complement activation in the anti-inflammatory properties of HDLJ Clin Invest2007117374675617332893
   PubMed Web of Science ®Google Scholar
• SpagnuoloMSCiglianoLD’AndreaLDPedoneCAbresciaPAssignment of the binding site for haptoglobin on apolipoprotein A-1J Biol Chem200528021193119815533931
   PubMed Web of Science ®Google Scholar
• KunitakeSTCarilliCTLauKProtterAANaya-VigneJKaneJPIdentification of proteins associated with apolipoprotein A-1 containing lipoproteins purified by selected-affinity immunosorbtionBiochemistry1994338198819938117655
   PubMed Web of Science ®Google Scholar
• RezaeeFCasettaBLevelsJHSpeijerDMeijersJCMProteomic analysis of high density lipoproteinProteomics20066272173016419016
   PubMed Web of Science ®Google Scholar
• AwadallahSHamadMThe prevalence of type II diabetes mellitus is haptoglobin phenotype independentCytobios200010139814515010755213
   PubMedGoogle Scholar
• WejmanJCHovsepianDWallJSHainfeldJFGreerJStructure and assembly of haptoglobin polymers by electron microscopyJ Mol Biol198417423433686716482
   PubMed Web of Science ®Google Scholar
• LevyAPHochbergIJablonskiKStrong Heart StudyHaptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart StudyJ Am Coll Cardiol200240111984199012475459
   PubMed Web of Science ®Google Scholar
• RoguinAKochWKastratiAAronsonDSchomigALevyAPHaptoglobin genotype is predictive of major adverse cardiac events in the one year period after PTCA in individuals with diabetesDiabetes Care20032692628263112941730
   PubMed Web of Science ®Google Scholar
• SuleimanMAronsonDAslehRHaptoglobin polymorphism predicts 30-day mortality and heart failure in patients with diabetes and acute myocardial infarctionDiabetes20055492802280616123372
   PubMed Web of Science ®Google Scholar
• CostacouTFerrellREOrchardTJHaptoglobin genotype: a determinant of cardiovascular complication risk in Type I diabetesDiabetes20085761702170618332093
   PubMed Web of Science ®Google Scholar
• ZhangYZanottiIReillyMPGlickJMRothblatGHRaderDJOverexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivoCirculation2003108666166312900335
   PubMed Web of Science ®Google Scholar
• AslehRMiller-LotanRAviramMHaptoglobin genotype is a regulator of reverse cholesterol transport in diabetes in vitro and in vivoCirc Res200699121419142517082477
   PubMed Web of Science ®Google Scholar
• AslehRGuettaJKalet-LitmanSMiller-LotanRLevyAPHaptoglobin genotype and diabetes dependent differences in iron mediated oxidative stress in vitro and in vivoCirc Res200596443544115662028
   PubMed Web of Science ®Google Scholar
• LevyAPGersteinHMiller-LotanRThe effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypesDiabetes Care20042711276715505023
   PubMed Web of Science ®Google Scholar
• YusufSDagenaisGPogueJBoschJSleightPVitamin E supplementation and cardiovascular events in high risk patients. The Heart Outcomes Prevention Evaluation Study InvestigatorsN Engl J Med2000342315416010639540
   PubMed Web of Science ®Google Scholar